Hereditary Spastic Paraparesis Latest Advances

MT-ATP6 variant as a cause of adult-onset hereditary spastic paraparesis: A case report and literature review.

Journal: Journal of neuromuscular diseases

Published: November 12, 2025

Serum NfL, but not GFAP, differentiates primary lateral sclerosis from adrenomyeloneuropathy and hereditary spastic paraplegia type 4.

Journal: Amyotrophic lateral sclerosis & frontotemporal degeneration

Published: September 17, 2025

Botulinum Toxin Treatment in Hereditary Spastic Paraplegia-A Comprehensive Review and Update.

Journal: Toxins

Published: September 04, 2025

Dorsolateral Cervical Cord T2 Hyperintensity in KIF1C-Related Disease (Spastic Paraplegia 58): Two Long-Duration Cases.

Journal: Annals of clinical and translational neurology

Published: August 31, 2025

Two homozygous KIF1C variants in a Turkish family presenting with cerebellar dysfunction and spastic paraparesis with MRI findings.

Journal: Parkinsonism & related disorders

Published: July 24, 2025

An atypical case of FA2H-related HSP35 with subtle neuroimaging findings and a novel variant in a young adult with spastic paraparesis.

Journal: Acta neurologica Belgica

Published: July 16, 2025

FA2H gene-associated spastic paraplegia (SPG35) - familial case with late onset

Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova

Published: June 03, 2025

Selection of Children with Spasticity Other Than Cerebral Palsy: Indications, Long-Term Outcome, and Exclusion Criteria.

Journal: Advances and technical standards in neurosurgery

Published: May 30, 2025

Maternal uniparental isodisomy in a patient with autosomal recessive spastic paraplegia type 20.

Journal: Gene

Published: April 08, 2025

HPDL Biallelic Variants in Cerebral Palsy and Childhood-Onset Hereditary Spastic Paraplegia: Human and Zebrafish Insights.

Journal: Movement disorders : official journal of the Movement Disorder Society

Published: March 25, 2025

Never Late: Cerebrotendinous Xanthomatosis and Improvements in Neurocognitive Functions in an Adult Patient on Chenodeoxycholic Acid Treatment.

Journal: Clinical genetics

Published: February 24, 2025

Clinical and Genetic Analyses of SPG7 in Japanese Patients with Undiagnosed Ataxia.

Journal: Internal medicine (Tokyo, Japan)

Published: February 02, 2025

Filters

MT-ATP6 variant as a cause of adult-onset hereditary spastic paraparesis: A case report and literature review.

MT-ATP6 variant as a cause of adult-onset hereditary spastic paraparesis: A case report and literature review.

Serum NfL, but not GFAP, differentiates primary lateral sclerosis from adrenomyeloneuropathy and hereditary spastic paraplegia type 4.

Serum NfL, but not GFAP, differentiates primary lateral sclerosis from adrenomyeloneuropathy and hereditary spastic paraplegia type 4.

Botulinum Toxin Treatment in Hereditary Spastic Paraplegia-A Comprehensive Review and Update.

Botulinum Toxin Treatment in Hereditary Spastic Paraplegia-A Comprehensive Review and Update.

Dorsolateral Cervical Cord T2 Hyperintensity in KIF1C-Related Disease (Spastic Paraplegia 58): Two Long-Duration Cases.

Dorsolateral Cervical Cord T2 Hyperintensity in KIF1C-Related Disease (Spastic Paraplegia 58): Two Long-Duration Cases.

Two homozygous KIF1C variants in a Turkish family presenting with cerebellar dysfunction and spastic paraparesis with MRI findings.

Two homozygous KIF1C variants in a Turkish family presenting with cerebellar dysfunction and spastic paraparesis with MRI findings.

An atypical case of FA2H-related HSP35 with subtle neuroimaging findings and a novel variant in a young adult with spastic paraparesis.

An atypical case of FA2H-related HSP35 with subtle neuroimaging findings and a novel variant in a young adult with spastic paraparesis.

FA2H gene-associated spastic paraplegia (SPG35) - familial case with late onset

FA2H gene-associated spastic paraplegia (SPG35) - familial case with late onset

Selection of Children with Spasticity Other Than Cerebral Palsy: Indications, Long-Term Outcome, and Exclusion Criteria.

Selection of Children with Spasticity Other Than Cerebral Palsy: Indications, Long-Term Outcome, and Exclusion Criteria.

Maternal uniparental isodisomy in a patient with autosomal recessive spastic paraplegia type 20.

Maternal uniparental isodisomy in a patient with autosomal recessive spastic paraplegia type 20.

HPDL Biallelic Variants in Cerebral Palsy and Childhood-Onset Hereditary Spastic Paraplegia: Human and Zebrafish Insights.

HPDL Biallelic Variants in Cerebral Palsy and Childhood-Onset Hereditary Spastic Paraplegia: Human and Zebrafish Insights.

Never Late: Cerebrotendinous Xanthomatosis and Improvements in Neurocognitive Functions in an Adult Patient on Chenodeoxycholic Acid Treatment.

Never Late: Cerebrotendinous Xanthomatosis and Improvements in Neurocognitive Functions in an Adult Patient on Chenodeoxycholic Acid Treatment.

Clinical and Genetic Analyses of SPG7 in Japanese Patients with Undiagnosed Ataxia.

Clinical and Genetic Analyses of SPG7 in Japanese Patients with Undiagnosed Ataxia.